Institute of Global Health, University of Geneva, Geneva, Switzerland.
Institute of Mathematical Statistics and Actuarial Science, University of Bern, Bern, Switzerland.
Trop Med Int Health. 2018 Nov;23(11):1223-1230. doi: 10.1111/tmi.13145. Epub 2018 Sep 19.
The 90-90-90 target states that by 2020, 90% of people living with HIV should be diagnosed, 90% of those diagnosed treated, and 90% of those treated virally suppressed. We assessed the actions needed in each country of sub-Saharan Africa to achieve the 90-90-90 target.
We developed a mathematical model to assess the number of patients needing to start antiretroviral therapy (ART) between 2017 and 2020 to achieve 81% coverage by 2020 in each country, and the proportion of treated patients who are virally suppressed in four scenarios, combining two scenarios of retention (current-level or perfect), and routine viral load monitoring (current or universal coverage). We performed two separate simulations, one using observed failure rates from cohort studies, and one with considerably lower failure rates to set a theoretical lower limit.
Our model projected that 2.9 million people started ART in 2017 in sub-Saharan Africa. If, depending on scenario, at least 2.2-2.7 million patients continue to start ART annually, 81% ART coverage will be reached in 2020 in sub-Saharan Africa on average. In 37% of the countries, a multiple-fold increase in annual number of patients starting ART is needed. Virological suppression >90% in 2020 could be reached only in the best-case scenario assuming low probability of treatment failure, elimination of treatment interruptions, and universal routine viral load monitoring.
The 90-90-90 target is realistic in sub-Saharan Africa on average, but not necessarily in all individual countries. Each country should identify and focus on the specific gaps needing attention.
90-90-90 目标指出,到 2020 年,应诊断出 90%的艾滋病毒感染者,将诊断出的 90%感染者纳入治疗,将治疗中的 90%感染者病毒抑制。我们评估了撒哈拉以南非洲各国实现 90-90-90 目标所需采取的行动。
我们开发了一个数学模型,以评估 2017 年至 2020 年期间需要开始抗逆转录病毒治疗(ART)的患者数量,以在每个国家实现 2020 年 81%的覆盖率,并评估在四种情况下接受治疗的患者中病毒抑制的比例,结合两种保留情况(当前水平或完美)和常规病毒载量监测(当前或普遍覆盖)。我们进行了两次单独的模拟,一次使用队列研究中的观察到的失败率,一次使用较低的失败率来设定理论下限。
我们的模型预测,2017 年撒哈拉以南非洲地区有 290 万人开始接受 ART。如果根据情况,至少有 220 万至 270 万人每年继续开始接受 ART,到 2020 年,撒哈拉以南非洲地区的 ART 覆盖率将平均达到 81%。在 37%的国家,需要使每年开始接受 ART 的患者数量增加数倍。只有在假设治疗失败概率低、消除治疗中断和普遍进行常规病毒载量监测的最佳情况下,2020 年才能实现病毒学抑制率 >90%。
90-90-90 目标在撒哈拉以南非洲地区平均上是现实的,但并非在所有国家都一定如此。每个国家都应确定并关注需要关注的具体差距。